Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. More Details
Excellent balance sheet with limited growth.
Share Price & News
How has Acutus Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AFIB is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: AFIB's weekly volatility (8%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: Insufficient data to determine how AFIB performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how AFIB performed against the US Market.
Long-Term Price Volatility Vs. Market
How volatile is Acutus Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Acutus Medical undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AFIB's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AFIB's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AFIB is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: AFIB is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AFIB's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AFIB is good value based on its PB Ratio (2.6x) compared to the US Medical Equipment industry average (4.6x).
How is Acutus Medical forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AFIB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AFIB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AFIB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AFIB's revenue (68.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: AFIB's revenue (68.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AFIB is forecast to be unprofitable in 3 years.
How has Acutus Medical performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: AFIB is currently unprofitable.
Growing Profit Margin: AFIB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if AFIB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare AFIB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AFIB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21.6%).
Return on Equity
High ROE: AFIB has a negative Return on Equity (-80.56%), as it is currently unprofitable.
How is Acutus Medical's financial position?
Financial Position Analysis
Short Term Liabilities: AFIB's short term assets ($151.4M) exceed its short term liabilities ($21.9M).
Long Term Liabilities: AFIB's short term assets ($151.4M) exceed its long term liabilities ($44.0M).
Debt to Equity History and Analysis
Debt Level: AFIB's debt to equity ratio (30.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if AFIB's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AFIB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AFIB has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 41.5% each year.
What is Acutus Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AFIB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AFIB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AFIB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AFIB's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AFIB's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Vince Burgess (55 yo)
Mr. Vincent J. Burgess, also known as Vince, has been President and Chief Executive Officer of Acutus Medical, Inc., since October 2017 and has been its Director since June 2013 and served as its Chairman ...
CEO Compensation Analysis
Compensation vs Market: Vince's total compensation ($USD532.32K) is below average for companies of similar size in the US market ($USD1.73M).
Compensation vs Earnings: Insufficient data to compare Vince's compensation with company performance.
Experienced Management: AFIB's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Experienced Board: AFIB's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: AFIB only recently listed within the past 12 months.
Acutus Medical, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Acutus Medical, Inc.
- Ticker: AFIB
- Exchange: NasdaqGS
- Founded: 2011
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$325.949m
- Shares outstanding: 28.12m
- Website: https://www.acutusmedical.com
Number of Employees
- Acutus Medical, Inc.
- 2210 Faraday Avenue
- Suite 100
- United States
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and inte...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/13 00:40|
|End of Day Share Price||2021/05/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.